Acetylcholinesterases: zymogens of neuropeptide processing enzymes?

Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

Journal of neurochemistry·2004

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

Journal of neuroscience research·2003

Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease.

Journal of Alzheimer's disease : JAD·2002

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.

Journal of neurochemistry·2001

The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.

European journal of biochemistry·2001

An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease.

Acta neurologica Scandinavica. Supplementum·2001

The organization of action stability during whole-body pointing: insights from drift and random-walk analyses.

Neuroscience·2026

Differential regulation of CYP46A1 in ischemic core and peri-infarct regions of male mouse brain after permanent middle cerebral artery occlusion.

Neuroscience·2026

Ketamine enhances ketogenic diet-induced resilience to activity-based anorexia of adult mice through hippocampal synaptic plasticity.

Neuroscience·2026

Effect of citicoline on cognitive function and functional recovery in patients with mild-to-moderate traumatic brain injury: a randomized placebo-controlled trial.

Neuroscience·2026

Altered topological organization of the brain functional networks in children with intellectual disability.

Neuroscience·2026

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Neuroscience·2026

Influence of sanguinarine on insulin amyloid fibrillogenesis: interaction, antifibrillation and defibrillation studies.

Physical chemistry chemical physics : PCCP·2026

Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases.

RSC advances·2026

Macrocyclic peptides and peptidomimetics as modulators of protein-protein interactions.

RSC medicinal chemistry·2026

Protein-based masks to unlock conditional activation of therapeutics.

Molecular therapy : the journal of the American Society of Gene Therapy·2026

Palladium-triggered bioorthogonal phenylalanine decaging.

Nature chemistry·2026

Related Experiment Videos

Acetylcholinesterases: zymogens of neuropeptide processing enzymes?

Related Concept Videos

Alpha7-nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones.

Glycosylation of acetylcholinesterase and butyrylcholinesterase changes as a function of the duration of Alzheimer's disease.

Neurite-outgrowth regulating functions of the amyloid protein precursor of Alzheimer's disease.

Wheat germ agglutinin-binding glycoproteins are decreased in Alzheimer's disease cerebrospinal fluid.

The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase.

An unusually glycosylated form of acetylcholinesterase is a CSF biomarker for Alzheimer's disease.

The organization of action stability during whole-body pointing: insights from drift and random-walk analyses.

Differential regulation of CYP46A1 in ischemic core and peri-infarct regions of male mouse brain after permanent middle cerebral artery occlusion.

Ketamine enhances ketogenic diet-induced resilience to activity-based anorexia of adult mice through hippocampal synaptic plasticity.

Effect of citicoline on cognitive function and functional recovery in patients with mild-to-moderate traumatic brain injury: a randomized placebo-controlled trial.

Altered topological organization of the brain functional networks in children with intellectual disability.

VAVL motor thalamus activity pattern changes following levodopa-induced dyskinesia in a rat model of Parkinson's disease.

Influence of sanguinarine on insulin amyloid fibrillogenesis: interaction, antifibrillation and defibrillation studies.

Recent medicinal chemistry efforts of targeting protein kinases for treating neurological conditions of Parkinson's and Alzheimer's diseases.

Macrocyclic peptides and peptidomimetics as modulators of protein-protein interactions.

Protein-based masks to unlock conditional activation of therapeutics.

Palladium-triggered bioorthogonal phenylalanine decaging.

Related Experiment Videos

Acetylcholinesterases: zymogens of neuropeptide processing enzymes?

Related Concept Videos

Related Articles